Our Approach

AI FIRST HEALTHCARE

The real unlock in healthcare isn’t AI-powered - it’s AI-native.

At GG Ventures, we back AI-native healthtech at the intersection of health, sports, and longevity. We're not interested on building on quick-sand nor optimising broken systems—we’re engineering the future.

We’re rewiring the lexicon and placing women at the epicenter of the longevity conversation for generations to come.

We’re retooling the hard drive—backing science-led, data-rich, AI-native platforms that redefine the boundaries of human potential.

This is the breakout decade for female performance. A brand-new world. And we’re building it.

Tunnel vision on:

Proprietary data moats — Longitudinal, multimodal, female-specific datasets with depth, velocity, and biological fidelity.
Predictive engines — Anticipating clinical need before it arises, delivering compounding value at scale.
Regulatory-grade infrastructure — Designed for payer alignment, compliance, and real-world clinical deployment.
IP & Scalable defensibility — Algorithms, biomarkers, or infrastructure that creates structural moats.

GG Ventures' Vision for Change

We’re not incremental—we’re foundational.

At GG Ventures, our female-led team are deploying for category creation and asymmetric outcomes.

We don’t just back bold founders—we’ve been them. With deep domain expertise and transatlantic firepower, we partner with iconic teams building enduring market leaders.

Optimizing female performance is a macroeconomic unlock—fueling families, fortifying the workforce, closing the longevity gap, and boosting GDP. It’s the key to solving the demographic crisis: declining birth rates, the retention of women in the workforce, and the sustainability of pension systems in aging nations.

Backing Breakout Innovation at the Inflection Point

Our investment thesis is simple: invest where the world isn’t looking—and own what the world will still need.

We deploy capital at the most catalytic stage - between Seed and Series A—where the right conviction, capital, and strategic network create asymmetric returns.

We back founders who aren’t just chasing product–market fit—they’re rebuilding from first principles with deep founder–market fit. US scale is built in or priced out—so we filter for friction on Day 0.

We’re not chasing momentum. We’re shaping markets. We’re building categories.